Gastroprotective effect and cytotoxicity of labdeneamides with amino acids

Planta Med. 2011 Mar;77(4):340-5. doi: 10.1055/s-0030-1250323. Epub 2010 Sep 22.

Abstract

Semisynthetic aromatic amides from ARAUCARIA ARAUCANA diterpene acids have been shown to display a relevant gastroprotective effect with low cytotoxicity. The aim of this work was to assess the gastroprotective effect of amino acid amides from imbricatolic acid and its 8(9)-en isomer in the ethanol/HCl-induced gastric lesions model in mice as well as to determine the cytotoxicity of the obtained compounds on the following human cell lines: normal lung fibroblasts (MRC-5), gastric adenocarcinoma (AGS), and liver hepatocellular carcinoma (Hep G2). The diterpenes 15-acetoxyimbricatolic acid, its 8(9)-en isomer, 15-hydroxyimbricatolic acid, and the 8(9)-en derivative, bearing a COOH function at C-19, were used as starting compounds. New amides with C-protected amino acids were prepared. The study reports the effect of a single oral administration of either compound 50 min before the induction of gastric lesions by ethanol/HCl. Some 20 amino acid monoamides were obtained. Dose-response experiments on the glycyl derivatives showed that at a single oral dose of 100 mg/kg, the compounds presented an effect comparable to the reference drug lansoprazole at 20 mg/kg and at 50 mg/kg reduced gastric lesions by about 50%. All derivatives obtained in amounts > 30 mg were compared at a single oral dose of 50 mg/kg. The best gastroprotective effect was observed for the exomethylene derivatives bearing a valine residue at C-19 either with an acetoxy or free hydroxy group at C-15. The tryptophanyl derivative from the acetate belonging to the 8,9-en series presented selective cytotoxicity against hepatocytes. The glycyl amide of 15-acetoxyimbricatolic acid was the most cytotoxic and less selective compound with IC₅₀ values between 47 and 103 µM for the studied cell lines. This is the first report on the obtention of semisynthetic amino acid amides from labdane diterpenes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / pharmacology
  • Adenocarcinoma / drug therapy
  • Amides / chemical synthesis
  • Amides / pharmacology
  • Amides / therapeutic use
  • Amino Acids / chemical synthesis
  • Amino Acids / pharmacology
  • Amino Acids / therapeutic use
  • Animals
  • Anti-Ulcer Agents / chemical synthesis
  • Anti-Ulcer Agents / pharmacology*
  • Anti-Ulcer Agents / therapeutic use
  • Antineoplastic Agents, Phytogenic / chemical synthesis
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Cell Line
  • Cell Line, Tumor
  • Cycadopsida / chemistry*
  • Disease Models, Animal
  • Diterpenes / isolation & purification
  • Diterpenes / pharmacology*
  • Diterpenes / therapeutic use
  • Ethanol
  • Fibroblasts / drug effects
  • Humans
  • Hydrochloric Acid
  • Isomerism
  • Lansoprazole
  • Liver Neoplasms / drug therapy
  • Male
  • Mice
  • Phytotherapy
  • Plant Extracts / chemical synthesis
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Stomach / drug effects*
  • Stomach / pathology
  • Stomach Neoplasms / drug therapy

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Amides
  • Amino Acids
  • Anti-Ulcer Agents
  • Antineoplastic Agents, Phytogenic
  • Diterpenes
  • Plant Extracts
  • imbricatolic acid
  • Lansoprazole
  • Ethanol
  • Hydrochloric Acid